期刊文献+

缬沙坦与氨氯地平用于老年高血压合并2型糖尿病82例效果观察 被引量:1

Effect Observation of Valsartan and Amlodipine for 82 Elderly Hypertensive Patients Combined with Type 2 Diabetes
在线阅读 下载PDF
导出
摘要 目的:观察缬沙坦和氨氯地平治疗老年高血压合并2型糖尿病的临床疗效。方法将120例患者随机分为缬沙坦组、氨氯地平组和联合治疗组各40例,比较三组患者的降压效果、血糖及肾功能指标。结果 C组的mALB明显低于A、B组,C组的降压效果明显优于A、B组。结论缬沙坦配伍氨氯地平治疗高血压合并2型糖尿病可以较好的控制患者的血压,同时还可以减轻靶器官损害,是治疗老年高血压合并2型糖尿病的理想方法。 Objective:To observe the ef ect of valsartan and amlodipine for 82 elderly hypertensive patients combined with type 2 diabetes.Methods:120 patients were randomly divided into valsartan,amlodipine group and combined treatment group of 40 patients in each group.The antihypertensive ef ect,blood glucose and renal function parameters were compared in the three groups of patients.Results:mALB of group C was statistical y significantly lower than those of patients in group A and group B.Group C had significantly bet er antihypertensive ef ect than those of patients in group A and group B.Conclusion:The treatment of valsartan combined with amlodipine in patients of hypertension and type 2 diabetes can ontrol the patient's blood pressure wel,and it also can reduce the damage of target organ,so it is the ideal way to treat elderly hypertensive patients with type 2 diabetes.
作者 陶汉蓉 TAO Han-rong(Yingjing County People's Hospital,Yingjing Sichuan 625200,China)
机构地区 荥经县人民医院
出处 《医学信息(医学与计算机应用)》 2014年第7期73-73,共1页 Medical Information
关键词 缬沙坦 氨氯地平 高血压 2型糖尿病 Valsartan Amlodipine Hypertension Type 2 diabetes
  • 相关文献

参考文献6

二级参考文献26

  • 1刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2621
  • 2崔学军,李焕杰,刘红霞,李玉华.缬沙坦联合氨氯地平治疗老年高血压的疗效观察[J].中国老年学杂志,2007,27(10):997-998. 被引量:30
  • 3Sowers J R, Epstein M, Frohlich E D. Diabetes, hypertension, and cardiovascular disease : an update [ J ]. Hypertension,2001,37(4) : 1053-1059
  • 4耿纪录 陈晓星 刘慧娟 等.血管紧张素Ⅱ受体拮抗剂的临床应用进展.中华中西医杂志,2000,1(10):903-905.
  • 5Hansson L,Zanchetti A, Carruthers S G, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group[ J ]. Lancet, 1998,351 ( 9118 ) : 1755-1762.
  • 6Anonymous. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group[ J ]. BMJ, 1998,317(7160) :703-713.
  • 7[1]Chalmers J. 1999 world health organization - international society of hypertension guidelines for the management of hypertension:guidelines subcomnittee[J].Journal of Hypertension, 1999, 17(2) :181-183
  • 8[2]Frohlich ED. Current clinical pathopysiologic considerations in essential hypertension [ J ]. Med Clini N Am,1997, 81(5): 1124
  • 9[3]Kobrin L, Frohlich E D. Renal involvement follows cardiac enlargement in essential hypertension[J]. Arch Intern Med, 1986, 146(2) :227
  • 10[5]Holm J, Henamingsen Z, Niclsen MD. Arteral blood pressure related to degree of albuminuria and low molecular weight proteinuria in IDDM [ J ]. Diabetes Care, 1990, 13: 443

共引文献84

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部